Description of the drug
Composition: Enterococcus faecalis strain M4-II-I in the number of viable cells not less than 108 CFU. This microorganism was selected according to the clinical data of stratified patients.
Characteristics
The unique author's probiotic strain E. faecalis M4 II I, which is the basis of the dietary supplement, is effective in the treatment of acute and chronic dermatitis (including atopic dermatitis, seborrheic dermatitis, acne, allergic dermatitis, etc.) The use of the drug helps to restore the balance of intestinal microbiota and intestinal barrier function, which provides protection against the penetration of allergens and toxins into the bloodstream. Harmlessness of the probiotic strain of the microorganism E. faecalis M4-II-I has been confirmed by genetic sequencing.